Posted by Michael Wonder on 01 Mar 2021
Rare Disease Day 2021: FDA shows sustained support of rare disease product development during the public health emergency
1 March 2021 - Rare Disease Day is a time to reflect on both the progress that has been made, and the work that needs to be done, to advance rare disease treatments.
The COVID-19 pandemic has added urgency, because people with rare diseases are among the most vulnerable to COVID-19.
The U.S. FDA is committed to supporting development of treatments for rare diseases.
Read FDA press release
